ArticleCrohn's & colitis 3602026
Gestational weight gain and birth outcomes in a large Canadian cohort of pregnant persons with inflammatory bowel disease.
Article in Crohn's & colitis 360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Pregnant persons with inflammatory bowel disease (IBD) are at increased risk of preterm delivery. We sought to characterize gestational weight gain (GWG) in this population and whether it is associated with birth outcomes. Methods: Pregnant patients with ulcerative colitis (UC), Crohn's disease (CD), and IBD-unclassified (IBD-U) were retrospectively identified at Mount Sinai Hospital from 2016 to 2020. Total GWG during pregnancy was categorized as inadequate, adequate, or excessive based on pre-pregnancy body mass index. Birth outcomes, including preterm delivery, small for gestational age (SGA), and large for gestational age, were recorded. Outcomes were compared among GWG groups. The association between GWG and outcomes was assessed using multiple logistic regression while controlling for confounders. Results: Two-hundred and twenty-five pregnancies were included (110 UC/IBD-U and 115 CD). The proportion of patients with inadequate, adequate, and excessive GWG was 21.3%, 40.4%, and 38.2%, respectively. The likelihood of preterm delivery did not differ among those with inadequate, adequate, and excessive GWG. The likelihood of SGA was lower in those with excessive GWG compared with those with inadequate and adequate GWG (7% vs 21% and 20%, respectively, Conclusions: Both inadequate and adequate GWG are common in pregnant persons with IBD. In our cohort, inadequate GWG was not associated with adverse birth outcomes, while excessive GWG appears to be protective against SGA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.